• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    HOPCo Expands its Musculoskeletal Population Health Program with Humana Partnership and its Arizona Members

    10/28/25 11:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care
    Get the next $HUM alert in real time by email

    HOPCo's unique specialty care platform, empowered with integrated analytics and member engaging digital tools, will align providers and members around clinical best practices and is now available for eligible Humana members receiving musculoskeletal (MSK) care across Arizona.

    PHOENIX, Oct. 28, 2025 /PRNewswire/ -- Healthcare Outcomes Performance Company (HOPCo), the global leader in integrated MSK value-based care solutions, MSK physician practice management, and specialty care clinically integrated networks, and leading health and well-being company, Humana Inc. (NYSE:HUM), have partnered to add Humana members in Arizona to HOPCo's advanced MSK population health solution. This partnership is designed to advance quality of care and help optimize patient health outcomes for eligible individuals living with musculoskeletal conditions.

    Healthcare Outcomes Performance (PRNewsfoto/Healthcare Outcomes Performance)

    HOPCo's proprietary platform, which includes integrated provider and patient digital engagement solutions, a comprehensive evidence-based care delivery infrastructure, and proven value-based care medical economics platform, is being deployed to a growing population of payors and members. HOPCo will use its digitally powered Integrated Care System (ICS) ensuring members with MSK conditions rapidly receive the correct therapies and care management with the most appropriate provider and in the most appropriate setting, all while being guided and monitored by MSK clinical experts adhering to evidence-based protocols through a unique combination of omnichannel in-person, virtual, and hybrid interactions.

    Unlike point solutions that often focus on a limited portion of the patient journey, HOPCo's value-based care platform engages members and providers across the entire MSK care continuum at all points of care. The platform utilizes proprietary digital engagement tools including myrecovery®, to engage members fully upstream with primary care providers (PCPs) as well as with MSK specialists through HOPCo's statewide clinically integrated network (CIN), the HOPCo Specialty Care Network (HSCN). HSCN, the only URAC-accredited MSK CIN in the country, has aligned more than 230 MSK specialty physicians across Arizona around clinical best practices, quality incentive metrics, and real-time claims analytics. Further underscoring HOPCo's continued growth of its fully integrated digital solutions, the company recently announced the acquisition of AI-powered digital health leader, Caro Health.

    "We continue to see great enthusiasm from payors and risk-bearing entities for HOPCo's proven solutions that engage members and all stakeholders aligning care around evidence-based best practices across all points of the patient journey," said Jason Scalise, MD, Chief Value Officer at HOPCo. "Our dedicated upstream PCP engagement platform combined with our statewide MSK specialty CIN, fully integrated digital engagement tools and sophisticated medical economics and analytics is far more effective than isolated point solutions. It is instead, a solution for every point of care." Additional payors and risk bearing entities in Arizona and across the US have engaged with HOPCo for similar large scale and durable MSK care solutions, he added.

    About Healthcare Outcomes Performance Company (HOPCo) 

    Healthcare Outcomes Performance Company (HOPCo) is the global leader in musculoskeletal (MSK) value-based care, outcomes management, and care transformation. HOPCo partners with physician practices, health systems, payors, and suppliers to implement clinically integrated models that improve quality, reduce variability, and lower the total cost of MSK care.

    Through HOPCo Digital, its advanced technology and AI platform, HOPCo is building the most comprehensive solution for practices, ambulatory surgery centers, payors, suppliers, and health systems enabling integrated, data-driven, and patient-centered care. HOPCo's global footprint includes partnerships worldwide, with teams on the ground supporting successful implementations in both emerging and mature healthcare systems and markets.

    Visit www.hopco.com to learn more.

    Follow us on LinkedIn, Instagram and Facebook

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/hopco-expands-its-musculoskeletal-population-health-program-with-humana-partnership-and-its-arizona-members-302596790.html

    SOURCE Healthcare Outcomes Performance Company

    Get the next $HUM alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HUM

    DatePrice TargetRatingAnalyst
    10/14/2025$235.00Sell
    Goldman
    9/22/2025$295.00In-line
    Evercore ISI
    5/1/2025$315.00Mkt Perform → Outperform
    Raymond James
    11/6/2024$247.00 → $308.00Underperform → Neutral
    BofA Securities
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    10/8/2024$308.00Mkt Perform → Outperform
    Bernstein
    10/7/2024$402.00 → $261.00Buy → Hold
    TD Cowen
    10/7/2024$519.00 → $253.00Buy → Hold
    Jefferies
    More analyst ratings

    $HUM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Humana Inc. to Present at 2025 Wolfe Research Healthcare Conference

    Humana Inc. (NYSE:HUM) announced today that Celeste Mellet, Chief Financial Officer, will make a presentation to investors at the Wolfe Research Healthcare Conference on Wednesday, November 19, 2025, at 8:40 a.m. Eastern time. A live audio webcast of the presentation will be available via Humana's Investor Relations page at https://humana.gcs-web.com/. The company suggests webcast participants sign on approximately 15 minutes in advance of the presentation to allow time to run a system test and download any free software needed for access purposes. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insuran

    11/6/25 4:15:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Reports Third Quarter 2025 Financial Results; Affirms Full Year 2025 Adjusted EPS Guidance

    Reports 3Q25 earnings per share (EPS) of $1.62 on a GAAP basis, Adjusted EPS of $3.24; reports YTD EPS of $16.43 on a GAAP basis, $21.10 on an Adjusted basis 3Q25 Insurance segment benefit ratio of 91.1 percent, in line with the company's previously disclosed expectation of 'just above 91 percent' Updates FY 2025 GAAP EPS guidance to 'approximately $12.26' from the previous estimate of 'approximately $13.77'; affirms Adjusted FY 2025 EPS guidance of 'approximately $17.00' Affirms FY 2025 Insurance segment benefit ratio guidance range of 90.1 percent to 90.5 percent Updates FY 2025 individual Medicare Advantage membership guidance to now anticipate a decline of 'approximately 425,00

    11/5/25 6:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    HOPCo Expands its Musculoskeletal Population Health Program with Humana Partnership and its Arizona Members

    HOPCo's unique specialty care platform, empowered with integrated analytics and member engaging digital tools, will align providers and members around clinical best practices and is now available for eligible Humana members receiving musculoskeletal (MSK) care across Arizona. PHOENIX, Oct. 28, 2025 /PRNewswire/ -- Healthcare Outcomes Performance Company (HOPCo), the global leader in integrated MSK value-based care solutions, MSK physician practice management, and specialty care clinically integrated networks, and leading health and well-being company, Humana Inc. (NYSE:HUM), have partnered to add Humana members in Arizona to HOPCo's advanced MSK population health solution. This partnership i

    10/28/25 11:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    SEC Filings

    View All

    SEC Form 10-Q filed by Humana Inc.

    10-Q - HUMANA INC (0000049071) (Filer)

    11/5/25 12:07:03 PM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HUMANA INC (0000049071) (Filer)

    11/5/25 6:11:16 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - HUMANA INC (0000049071) (Filer)

    10/2/25 12:00:03 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Rechtin James A. bought $1,496,984 worth of Humana Common (6,530 units at $229.25) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    5/16/25 4:48:13 PM ET
    $HUM
    Medical Specialities
    Health Care

    Mesquita Jorge S. bought $200,066 worth of Humana Common (545 units at $367.09) (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/21/24 10:37:23 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Humana with a new price target

    Goldman initiated coverage of Humana with a rating of Sell and set a new price target of $235.00

    10/14/25 8:50:11 AM ET
    $HUM
    Medical Specialities
    Health Care

    Evercore ISI initiated coverage on Humana with a new price target

    Evercore ISI initiated coverage of Humana with a rating of In-line and set a new price target of $295.00

    9/22/25 8:31:23 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana upgraded by Raymond James with a new price target

    Raymond James upgraded Humana from Mkt Perform to Outperform and set a new price target of $315.00

    5/1/25 7:42:13 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Smith Gordon converted options into 765 units of Humana Common (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    11/4/25 9:45:30 AM ET
    $HUM
    Medical Specialities
    Health Care

    President, Insurance Renaudin George Ii converted options into 609 units of Humana Common and covered exercise/tax liability with 240 units of Humana Common, increasing direct ownership by 2% to 16,071 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    10/3/25 9:13:54 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form 4 filed by Director Feinberg David T

    4 - HUMANA INC (0000049071) (Issuer)

    10/2/25 1:07:38 PM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Leadership Updates

    Live Leadership Updates

    View All

    National Mall of Pickleball Returns for Third Year with Expanded Footprint and New, Central Location

    The National Mall of Pickleball will celebrate America's most accessible sport and the game that serves all in the heart of the National Mall this September The Trust for the National Mall, Humana (NYSE:HUM), and the Humana Foundation announced today that the highly-anticipated National Mall of Pickleball is returning to America's Front Yard, the National Mall, for a third year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625316935/en/ From Friday, September 19 through Sunday, September 21, 2025, the general public can experience a weekend full of pickleball programming, activities, and community with captivating views o

    6/25/25 9:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Launches "Invite" Campaign to Inspire Active Aging Through Pickleball and Community Connection

    Humana Inc. (NYSE:HUM), a leading health and well-being company, is expanding its commitment to senior wellness with the launch of Invite, a new campaign designed to encourage older adults of all fitness levels to stay active, connected and engaged – starting with the fastest-growing sport in America: pickleball. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618737488/en/As part of Humana's new "Invite" campaign, the health and wellness company debuted a television spot featuring senior pickleball athletes extending an open invitation to others to join the fun, stay social, and support their physical and mental well-being. A

    6/18/25 8:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Announces CFO Transition

    Leading health and well-being company Humana Inc. (NYSE:HUM) announced today that Celeste Mellet will be appointed to succeed Susan Diamond as Chief Financial Officer (CFO), effective January 11, 2025. Diamond is stepping down after a successful 18-year career at Humana, including over three years as CFO, and will serve in an advisory role through the end of 2025 to ensure a smooth transition. "On behalf of the entire Board and management team, I want to extend my thanks to Susan for her leadership as CFO and in prior roles during her nearly two decades at Humana," said Jim Rechtin, Humana's President and Chief Executive Officer. "Susan's contributions spanned across our Medicare, Home So

    12/3/24 8:05:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Financials

    Live finance-specific insights

    View All

    Humana Reports Third Quarter 2025 Financial Results; Affirms Full Year 2025 Adjusted EPS Guidance

    Reports 3Q25 earnings per share (EPS) of $1.62 on a GAAP basis, Adjusted EPS of $3.24; reports YTD EPS of $16.43 on a GAAP basis, $21.10 on an Adjusted basis 3Q25 Insurance segment benefit ratio of 91.1 percent, in line with the company's previously disclosed expectation of 'just above 91 percent' Updates FY 2025 GAAP EPS guidance to 'approximately $12.26' from the previous estimate of 'approximately $13.77'; affirms Adjusted FY 2025 EPS guidance of 'approximately $17.00' Affirms FY 2025 Insurance segment benefit ratio guidance range of 90.1 percent to 90.5 percent Updates FY 2025 individual Medicare Advantage membership guidance to now anticipate a decline of 'approximately 425,00

    11/5/25 6:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    HOPCo Expands its Musculoskeletal Population Health Program with Humana Partnership and its Arizona Members

    HOPCo's unique specialty care platform, empowered with integrated analytics and member engaging digital tools, will align providers and members around clinical best practices and is now available for eligible Humana members receiving musculoskeletal (MSK) care across Arizona. PHOENIX, Oct. 28, 2025 /PRNewswire/ -- Healthcare Outcomes Performance Company (HOPCo), the global leader in integrated MSK value-based care solutions, MSK physician practice management, and specialty care clinically integrated networks, and leading health and well-being company, Humana Inc. (NYSE:HUM), have partnered to add Humana members in Arizona to HOPCo's advanced MSK population health solution. This partnership i

    10/28/25 11:00:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Humana Board Declares Payment of Quarterly Dividend to Stockholders

    Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on January 30, 2026 to stockholders of record as of the close of business on December 26, 2025. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, mili

    10/28/25 6:30:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    $HUM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/16/24 4:29:43 PM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/14/24 10:02:59 AM ET
    $HUM
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Humana Inc. (Amendment)

    SC 13G/A - HUMANA INC (0000049071) (Subject)

    2/13/24 5:06:27 PM ET
    $HUM
    Medical Specialities
    Health Care